Pharmacoeconomic analisis of the treatment with leflunomide-methotrexate or infliximab-methotrexate in patients with rheumatoid arthritis resistant to methotrexate

被引：0
|
作者：
Terrés, RC
Romero, F
Burrell, A
Domínguez-Gil, A
机构：
[1] Aventis Pharma SA, Madrid, Spain
[2] Aventis, Bridgewater, NJ USA
[3] Hosp Univ, Salamanca, Spain
来源：
VALUE IN HEALTH | 2002年 / 5卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：475 / 475
页数：1
相关论文
共 50 条
  • [1] Infliximab and methotrexate in the treatment of rheumatoid arthritis
    Lipsky, PE
    van der Heijde, DMFM
    St Clair, EW
    Furst, DE
    Breedveld, FC
    Kalden, JR
    Smolen, JS
    Weisman, M
    Emery, P
    Feldmann, M
    Harriman, GR
    Maini, RN
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (22): : 1594 - 1602
  • [2] Combination treatment with leflunomide and methotrexate for patients with active rheumatoid arthritis
    Lee, S-S.
    Park, Y-W.
    Park, J. J.
    Kang, Y. M.
    Nam, E. J.
    Kim, S. I.
    Lee, J. H.
    Yoo, W-H.
    Lee, S-I.
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2009, 38 (01) : 11 - 14
  • [3] Leflunomide or methotrexate for juvenile rheumatoid arthritis
    Silverman, E
    Mouy, R
    Spiegel, L
    Jung, LK
    Saurenmann, RK
    Lahdenne, P
    Horneff, G
    Calvo, I
    Szer, IS
    Simpson, K
    Stewart, JA
    Strand, V
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (16): : 1655 - 1666
  • [4] Combination treatment with infliximab and methotrexate or leflunomide in active rheumatoid arthritis. Safety and efficacy
    Athanassiou, P
    Kostoglou-Athanassiou, I
    Koutsogeorgopoulou, L
    Galanaki, C
    Kordalis, A
    Konstantopoulou, R
    Sarlanis, T
    Vezyroglou, G
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 464 - 464
  • [5] OSTEOPOROSIS IN PATIENTS WITH RHEUMATOID ARTHRITIS: METHOTREXATE COMPARED WITH LEFLUNOMIDE TREATMENT ALONE
    Ganea, N.
    Groppa, L.
    Russu, E.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2014, 25 : S324 - S325
  • [6] CHARACTERISITCS OF PATIENTS RECEIVING LEFLUNOMIDE, METHOTREXATE OR LEFLUNOMIDE PLUS METHOTREXATE FOR THE TREATMENT OF RHEUMATOID ARTHRITIS IN A REAL-LIFE SETTING IN COLOMBIA
    Santos-Moreno, R.
    Villarreal Peralta, L.
    Jaimes, H.
    Jaimes, J.
    Buitrago-Garcia, D.
    Castro, C.
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A941 - A941
  • [7] Response to the letter by Ahumada et al about the article: "Pharmacoeconomic analysis of the treatment of methotrexateresistant rheumatoid arthritis with combinations of leflunomidemethotrexate or infliximab-methotrexate"
    Rubio-Terres, Carlos
    Romero, Fredeswinda I.
    Burrell, Anita
    Dominguez-Gil Hurle, Alfonso
    [J]. REUMATOLOGIA CLINICA, 2006, 2 (06): : 332 - 333
  • [8] Safety and efficacy of leflunomide and infliximab versus methotrexate and infliximab combination therapy in rheumatoid arthritis
    Ibáñez, TC
    Tayel, MY
    Criado, AB
    Sanz, AH
    Mola, E
    [J]. RHEUMATOLOGY, 2005, 44 (11) : 1467 - 1468
  • [9] Safety and efficacy of the association of leflunomide-infliximab versus methotrexate-infliximab in patients with rheumatoid arthritis
    Ibañez, TC
    Tayel, MY
    Sanz, AH
    Criado, AB
    Martín-Mola, E
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 469 - 469
  • [10] Methotrexate dosage reduction in patients with rheumatoid arthritis beginning therapy with infliximab: the Infliximab Rheumatoid Arthritis Methotrexate Tapering (iRAMT) trial
    Fleischmann, RM
    Cohen, SB
    Moreland, LW
    Schiff, M
    Mease, PJ
    Smith, DB
    Keenan, G
    Kremer, JM
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (08) : 1181 - 1190
12345